AlphaCrest Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,040
| Closed | -$84K | – | 1326 |
|
|
2022
Q1 | $84K | Sell |
1,040
-4,300
| -81% | -$347K | ﹤0.01% | 1219 |
|
|
2021
Q4 | $1.08M | Buy |
5,340
+3,894
| +269% | +$789K | 0.04% | 751 |
|
|
2021
Q3 | $390K | Sell |
1,446
-6,695
| -82% | -$1.81M | 0.02% | 1013 |
|
|
2021
Q2 | $2.1M | Buy |
8,141
+7,373
| +960% | +$1.9M | 0.09% | 350 |
|
|
2021
Q1 | $230K | Sell |
768
-49
| -6% | -$14.7K | 0.01% | 1098 |
|
|
2020
Q4 | $208K | Sell |
817
-451
| -36% | -$115K | 0.02% | 1069 |
|
|
2020
Q3 | $316K | Buy |
+1,268
| New | +$316K | 0.03% | 830 |
|
|
2019
Q4 | – | Sell |
-980
| Closed | -$268K | – | 1325 |
|
|
2019
Q3 | $268K | Buy |
+980
| New | +$268K | 0.02% | 1131 |
|